CURE vs. ICLN
CURE (Direxion Daily Healthcare Bull 3x Shares) and ICLN (iShares Global Clean Energy ETF) are both exchange-traded funds - CURE is a Leveraged Equities fund tracking the Health Care Select Sector Index (300%), while ICLN is a Alternative Energy Equities fund tracking the S&P Global Clean Energy Index. Both are passively managed. Over the past 10 years, CURE returned 15.35%/yr vs 11.35%/yr for ICLN. At a 0.43 correlation, their price movements are largely independent. CURE charges 1.08%/yr vs 0.39%/yr for ICLN.
Performance
CURE vs. ICLN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE achieves a -3.98% return, which is significantly lower than ICLN's 23.83% return. Over the past 10 years, CURE has outperformed ICLN with an annualized return of 15.35%, while ICLN has yielded a comparatively lower 11.35% annualized return.
CURE
- 1D
- 4.52%
- 1M
- 14.41%
- YTD
- -3.98%
- 6M
- -6.03%
- 1Y
- 39.34%
- 3Y*
- 4.46%
- 5Y*
- 1.58%
- 10Y*
- 15.35%
ICLN
- 1D
- -0.93%
- 1M
- -11.28%
- YTD
- 23.83%
- 6M
- 22.71%
- 1Y
- 58.94%
- 3Y*
- 6.01%
- 5Y*
- -1.22%
- 10Y*
- 11.35%
CURE vs. ICLN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | -3.98% | 22.55% | -8.47% | -9.40% | -20.51% | 88.30% | 5.02% | 55.66% | 2.82% | 69.32% |
ICLN iShares Global Clean Energy ETF | 23.83% | 47.05% | -25.72% | -20.41% | -5.43% | -24.18% | 141.82% | 44.36% | -9.03% | 21.47% |
Correlation
The correlation between CURE and ICLN is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.24 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.33 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.39 |
Correlation (All Time) Calculated using the full available price history since Jun 15, 2011 | 0.43 |
Over the past year, the correlation between CURE and ICLN has dropped to 0.12 - well below their long-term average of 0.43, suggesting their price drivers have been diverging.
CURE vs. ICLN - Sectors Allocation Comparison
Sectors
CURE
ICLN
Healthcare
-
Basic Materials
-
Communication Services
-
-
Consumer Cyclical
-
Consumer Defensive
-
-
Energy
-
Financial Services
-
-
Industrials
-
Real Estate
-
-
Technology
-
Utilities
-
Healthcare
CURE
ICLN
-
Basic Materials
CURE
-
ICLN
Communication Services
CURE
-
ICLN
-
Consumer Cyclical
CURE
-
ICLN
Consumer Defensive
CURE
-
ICLN
-
Energy
CURE
-
ICLN
Financial Services
CURE
-
ICLN
-
Industrials
CURE
-
ICLN
Real Estate
CURE
-
ICLN
-
Technology
CURE
-
ICLN
Utilities
CURE
-
ICLN
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE vs. ICLN — Risk / Return Rank
CURE
ICLN
CURE vs. ICLN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and iShares Global Clean Energy ETF (ICLN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CURE | ICLN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.19 | ||
| Sortino ratioReturn per unit of downside risk | -1.12 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.33 | -0.16 |
| Calmar ratioReturn relative to maximum drawdown | 1.27 | 3.62 | -2.35 |
| Martin ratioReturn relative to average drawdown | 2.81 | 12.13 | -9.32 |
Loading charts...
Drawdowns
CURE vs. ICLN - Drawdown Comparison
The maximum CURE drawdown since its inception was -69.19%, smaller than the maximum ICLN drawdown of -87.15%. Use the drawdown chart below to compare losses from any high point for CURE and ICLN.
Loading charts...
Drawdown Indicators
| CURE | ICLN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.19% | -87.15% | +17.96% |
Max Drawdown (1Y)Largest decline over 1 year | -31.10% | -16.38% | -14.72% |
Max Drawdown (3Y)Largest decline over 3 years | -51.93% | -43.18% | -8.75% |
Max Drawdown (5Y)Largest decline over 5 years | -52.23% | -57.16% | +4.93% |
Max Drawdown (10Y)Largest decline over 10 years | -69.19% | -66.75% | -2.44% |
Current DrawdownCurrent decline from peak | -23.78% | -44.60% | +20.82% |
Average DrawdownAverage peak-to-trough decline | -18.18% | -66.52% | +48.34% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.04% | 4.87% | +9.17% |
Volatility
CURE vs. ICLN - Volatility Comparison
Direxion Daily Healthcare Bull 3x Shares (CURE) has a higher volatility of 15.54% compared to iShares Global Clean Energy ETF (ICLN) at 13.11%. This indicates that CURE's price experiences larger fluctuations and is considered to be riskier than ICLN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CURE | ICLN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.54% | 13.11% | +2.43% |
Volatility (6M)Calculated over the trailing 6-month period | 31.42% | 23.13% | +8.29% |
Volatility (1Y)Calculated over the trailing 1-year period | 44.65% | 28.51% | +16.14% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.97% | 27.69% | +16.28% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.58% | 27.32% | +22.26% |
CURE vs. ICLN - Expense Ratio Comparison
CURE has a 1.08% expense ratio, which is higher than ICLN's 0.39% expense ratio.
Dividends
CURE vs. ICLN - Dividend Comparison
CURE's dividend yield for the trailing twelve months is around 1.18%, more than ICLN's 0.91% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.18% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% | 0.00% | 0.00% |
ICLN iShares Global Clean Energy ETF | 0.91% | 1.63% | 1.85% | 1.59% | 0.89% | 1.18% | 0.34% | 1.36% | 2.77% | 2.49% | 3.88% | 2.36% |
Frequently Asked Questions
CURE and ICLN have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CURE has higher volatility (15.54%) compared to ICLN (13.11%). In terms of maximum drawdown, CURE dropped -69.19% vs ICLN's -87.15%.
On 10-year performance, CURE leads with 15.35% vs 11.35% for ICLN. On fees, ICLN is cheaper at 0.39% per year. On volatility, ICLN has been the lower-risk option at 13.11%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, CURE has performed better with a 15.35% return vs 11.35%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
ICLN is cheaper with a 0.39% expense ratio, compared with 1.08% for CURE.
CURE has the higher dividend yield at 1.18%, compared with 0.91% for ICLN.
CURE is categorized as Leveraged Equities, while ICLN is Alternative Energy Equities. CURE tracks Health Care Select Sector Index (300%), while ICLN tracks S&P Global Clean Energy Index. They also come from different issuers: Direxion and iShares. Their fees differ too: 1.08% for CURE and 0.39% for ICLN.
ICLN currently has the higher Sharpe Ratio (2.08 vs 0.89), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CURE and ICLN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer